LIFE
Ethos Technologies Inc. Class A Common StockNASDAQFINANCIAL SERVICESINSURANCE BROKERS
Key Statistics
Market Cap
$790.27M
P/E Ratio
11.03
EPS
$1.14
Beta
—
52W High
$19.00
52W Low
$9.45
50-Day MA
$11.82
200-Day MA
$11.82
Dividend Yield
—
Profit Margin
18.40%
Forward P/E
—
PEG Ratio
—
About Ethos Technologies Inc. Class A Common Stock
aTyr Pharma, Inc., a clinical-stage biotherapeutics company, is dedicated to the discovery and development of drugs based on new immune pathways in the United States. The company is headquartered in San Diego, California.
Fundamentals
| Revenue (TTM) | $387.61M |
| Gross Profit (TTM) | $380.88M |
| EBITDA | $78.28M |
| Operating Margin | 22.20% |
| Return on Equity | 21.00% |
| Return on Assets | 10.00% |
| Revenue/Share (TTM) | $23.51 |
| Book Value | $-1.45 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | 2.04 |
| EV/Revenue | 1.61 |
| EV/EBITDA | 7.32 |
| Quarterly Earnings Growth (YoY) | 161.60% |
| Quarterly Revenue Growth (YoY) | 65.50% |
| Shares Outstanding | $30.79M |
| Float | $25.92M |
| % Insiders | 12.19% |
| % Institutions | 42.11% |
Analyst Ratings
Consensus ($20.25 target)
3
Strong Buy6
BuyData last updated: 4/8/2026